GH/IGF-I axis in azoospermia in primary and secondary hypogonadism: a study before and during replacement therapy.

The growth hormone/insulin-like growth factor-I (GH/IGF-I) axis was studied in 15 azoospermic patients and in 10 control men. Eight patients were affected by hypergonadotrophic hypogonadism and 7 by hypogonadotrophic hypogonadism. All were studied before and during replacement therapy with testosterone and gonadotrophin, respectively, using the alpha 2 adrenergic agonist, clonidine (clonidine test). The data demonstrate no differences in basal levels for IGF-I and for the GH response to clonidine in azoospermic patients, affected by primary and secondary hypogonadism, before and during replacement therapy when compared with control fertile men. In contrast to some studies which describe a reduced GH response in azoospermia and oligozoospermia, we conclude that basal serum levels of IGF-I and the GH response to clonidine are not impaired in azoospermic patients affected by primary hypogonadism before and after the restoration of normal androgenization, and in azoospermic patients affected by secondary hypogonadism, both before and after restoration of spermatogenesis.

[1]  A. Rogol,et al.  Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. , 1997, The Journal of clinical endocrinology and metabolism.

[2]  E. Ghigo,et al.  The effects of Clonidine on blood pressure, catecholamine and growth hormone release in hypogonadal men is preserved and not influenced by testosterone replacement therapy , 1996, Journal of endocrinological investigation.

[3]  B. Keenan,et al.  The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion. , 1996, The Journal of clinical endocrinology and metabolism.

[4]  E. Ghigo,et al.  Effect of testosterone replacement therapy on the somatotrope responsiveness to GHRH alone or combined with pyridostigmine and on sympathoadrenal activity in patients with hypogonadism , 1995, Journal of endocrinological investigation.

[5]  R. Clayton,et al.  Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin‐like growth factor‐l and urinary growth hormone excretion , 1995, Clinical endocrinology.

[6]  J. Queraltó,et al.  Growth hormone response to growth hormone-releasing hormone stimulation in oligozoospermic patients. , 1994, Fertility and sterility.

[7]  K. Ho,et al.  Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. , 1993, The Journal of clinical endocrinology and metabolism.

[8]  M. Ron,et al.  Growth hormone status in patients with maturation arrest of spermatogenesis. , 1993, Human reproduction.

[9]  A. Rogol,et al.  The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence. , 1992, Endocrine reviews.

[10]  A. Rogol,et al.  Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-life. , 1990, The Journal of clinical endocrinology and metabolism.

[11]  E. Stark,et al.  Loss of the effects of clonidine on the growth hormone release and hypotensive action in long-term castrated rats: the possible role of testosterone on alpha-2-adrenergic mechanisms of clonidine. , 1990, Neuroendocrinology.

[12]  A. Hoffman,et al.  Androgens do not regulate the growth hormone response to GHRH in elderly men. , 1989, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[13]  B. Burguera,et al.  GROWTH HORMONE AND PROLACTIN SECRETION AFTER GROWTH HORMONE‐RELEASING HORMONE ADMINISTRATION, IN ANOREXIA NERVOSA PATIENTS, NORMAL CONTROLS AND TAMOXIFEN‐PRETREATED VOLUNTEERS , 1987, Clinical endocrinology.

[14]  E. Ghigo,et al.  Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature. , 1987, The Journal of clinical endocrinology and metabolism.

[15]  J. Jansson,et al.  Endogenous testosterone enhances growth hormone (GH)-releasing factor-induced GH secretion in vitro. , 1987, The Journal of endocrinology.

[16]  G. Merriam,et al.  Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. , 1987, The Journal of clinical endocrinology and metabolism.

[17]  J. V. Van Wyk,et al.  Somatomedin-C and the assessment of growth. , 1980, Pediatric clinics of North America.

[18]  L. Levitsky,et al.  Effect of androgen on growth hormone secretion and growth in boys with short stature. , 1979, Acta endocrinologica.

[19]  A. Prader,et al.  Effect of testosterone on growth hormone secretion in patients with anorchia and delayed puberty. , 1970, The Journal of clinical endocrinology and metabolism.

[20]  V. Han.  The ontogeny of growth hormone, insulin-like growth factors and sex steroids: molecular aspects. , 1996, Hormone research.

[21]  H. Orskov,et al.  Impaired growth hormone secretion and increased growth hormone-binding protein levels in subfertile males. , 1996, Fertility and sterility.

[22]  J. Devesa,et al.  Growth hormone (GH) responsiveness to GHRH in normal adults is not affected by short-term gonadal blockade. , 1989, Acta endocrinologica.

[23]  A. Rogol,et al.  The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males. , 1986, The Journal of clinical endocrinology and metabolism.